However, type 1 diabetes also involves the dysregulation of the hormone glucagon, which is secreted in the pancreas in ...

This suggests that glucagon analogs could be a promising treatment option for patients experiencing postbariatric hypoglycemia. Additionally, digital health solutions are emerging as valuable ...

More information: A Glucose-Responsive Glucagon-Micelle for the Prevention of Hypoglycemia, ACS Central Science (2024). DOI: 10.1021/acscentsci.4c00937 Provided by American Chemical Society ...

The FDA approved Gvoke, a ready-to-use glucagon product, for the treatment of severe hypoglycemia in 2019. The format is potentially more convenient than traditional glucagon kits from the likes ...

According to the ADA, nearly half of all people with type 1 diabetes suffer from at least one severe hypoglycemia event each year. For people with type 2 diabetes, that number is about 21%. Glucagon ...